F2 and transient ischemic attack: A higher prevalence of the G20210A prothrombin mutation was reported in AF subjects compared with healthy controls, yet in these studies, the presence of the prothrombin mutation was not associated with an increased risk of thromboembolic events (stroke, transient ischemic attack, or peripheral embolism) [17,18].